AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
CHLORTETRACYCLINE
9 registrations across 3 African markets— 6 active
Markets with CHLORTETRACYCLINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| AUREOMYCINE SPECIA Pommade dermique / 3% | 🇹🇳Tunisia | TERIAK | expired | Mar 2004 |
| ORECYCLINE Pommade ophtalmique / 1% | 🇹🇳Tunisia | SIPHAT | expired | May 1994 |
| ORECYCLINE Pommade dermique / 3% | 🇹🇳Tunisia | SIPHAT | expired | Dec 1993 |
| AUREOMYCINE 1% POMMADE OPHTALMIQUE | 🇲🇦Morocco | — | active | — |
| Kepro CTC 20% WSP Water Soluble Powder | 🇹🇿Tanzania | Kepro B.V | active | — |
| AUREOMYCINE 3% POMMADE | 🇲🇦Morocco | — | active | — |
| CHLORTETRACYCLINE LAPROPHAN POMMADE | 🇲🇦Morocco | — | active | — |
| Castralin-200 WS Powder for Oral solution | 🇹🇿Tanzania | Interchemie Werken "De Adelaar" B.V | active | — |
| CHLORTETRACYCLINE LAPROPHAN POMMADE OPHTALMIQUE | 🇲🇦Morocco | — | active | — |
CHLORTETRACYCLINE in Africa — Regulatory Overview
CHLORTETRACYCLINE is registered across 3 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Tunisia, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 6 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.